Peter N.R. Heseltine

2.3k total citations
71 papers, 1.7k citations indexed

About

Peter N.R. Heseltine is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Peter N.R. Heseltine has authored 71 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 22 papers in Epidemiology and 21 papers in Pharmacology. Recurrent topics in Peter N.R. Heseltine's work include Antibiotics Pharmacokinetics and Efficacy (21 papers), HIV Research and Treatment (14 papers) and Appendicitis Diagnosis and Management (13 papers). Peter N.R. Heseltine is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (21 papers), HIV Research and Treatment (14 papers) and Appendicitis Diagnosis and Management (13 papers). Peter N.R. Heseltine collaborates with scholars based in United States, United Kingdom and Japan. Peter N.R. Heseltine's co-authors include Maria D. Appleman, Thomas V. Berne, Albert E. Yellin, M A Gill, John M. Leedom, Ron M. Kagan, Joseph Nussbaum, Mark A. Gill, Charles E. Cherubin and Charles W. Stratton and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Stroke.

In The Last Decade

Peter N.R. Heseltine

71 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter N.R. Heseltine United States 24 652 416 373 249 234 71 1.7k
Kjell Alestig Sweden 24 1.1k 1.7× 650 1.6× 339 0.9× 170 0.7× 59 0.3× 82 2.2k
Phillip F. Pierce United States 20 761 1.2× 452 1.1× 300 0.8× 147 0.6× 187 0.8× 42 1.5k
Dante Bassetti Italy 20 379 0.6× 647 1.6× 132 0.4× 65 0.3× 249 1.1× 72 1.3k
Ragnar Norrby Sweden 23 1.2k 1.8× 754 1.8× 339 0.9× 187 0.8× 78 0.3× 80 2.5k
Richard J. Duma United States 26 1.1k 1.7× 1.0k 2.4× 225 0.6× 131 0.5× 58 0.2× 77 2.5k
Y Mouton France 25 1.1k 1.7× 1.3k 3.1× 236 0.6× 160 0.6× 1.1k 4.7× 136 3.3k
R. F. Jacobs United States 22 1.2k 1.8× 1.1k 2.6× 324 0.9× 186 0.7× 87 0.4× 51 2.5k
Darwin L. Palmer United States 22 638 1.0× 534 1.3× 111 0.3× 85 0.3× 443 1.9× 50 2.0k
E Soriano Spain 18 770 1.2× 641 1.5× 140 0.4× 190 0.8× 80 0.3× 55 1.5k
E. J. C. Goldstein United States 22 560 0.9× 807 1.9× 242 0.6× 186 0.7× 120 0.5× 43 1.9k

Countries citing papers authored by Peter N.R. Heseltine

Since Specialization
Citations

This map shows the geographic impact of Peter N.R. Heseltine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter N.R. Heseltine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter N.R. Heseltine more than expected).

Fields of papers citing papers by Peter N.R. Heseltine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter N.R. Heseltine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter N.R. Heseltine. The network helps show where Peter N.R. Heseltine may publish in the future.

Co-authorship network of co-authors of Peter N.R. Heseltine

This figure shows the co-authorship network connecting the top 25 collaborators of Peter N.R. Heseltine. A scholar is included among the top collaborators of Peter N.R. Heseltine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter N.R. Heseltine. Peter N.R. Heseltine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Jin‐Man, András Gruber, Peter N.R. Heseltine, et al.. (2024). New Directions in Infection-Associated Ischemic Stroke. Journal of Clinical Neurology. 20(2). 140–140. 6 indexed citations
2.
Boos, Christopher J., et al.. (2015). High Altitude and Acute Mountain Sickness and Changes in Circulating Endothelin-1, Interleukin-6, and Interleukin-17a. High Altitude Medicine & Biology. 17(1). 25–31. 54 indexed citations
3.
Koski, Eileen, et al.. (2006). Exploring the Role of Quest Diagnostics Corporate Data Warehouse for Timely Influenza Surveillance. 1 indexed citations
4.
Winters, Mark A., Ron M. Kagan, Peter N.R. Heseltine, & Thomas C. Merigan. (2005). New Two-Amino Acid Insertion Near Codon 70 of the HIV Type 1 Protease Gene. AIDS Research and Human Retroviruses. 21(4). 311–313. 7 indexed citations
5.
Kagan, Ron M., Mark A. Winters, Thomas C. Merigan, & Peter N.R. Heseltine. (2004). HIV Type 1 Genotypic Resistance in a Clinical Database Correlates with Antiretroviral Utilization. AIDS Research and Human Retroviruses. 20(1). 1–9. 15 indexed citations
6.
Heseltine, Peter N.R.. (2000). Has resistance spread to the community?. Clinical Microbiology and Infection. 6. 11–16. 19 indexed citations
7.
Sarin, Prem S., James E. Talmadge, Peter N.R. Heseltine, et al.. (1999). Booster immunization of HIV-1 negative volunteers with HGP-30 vaccine induces protection against HIV-1 virus challenge in SCID mice. Vaccine. 17(1). 64–71. 8 indexed citations
8.
Skinner, G. R. B., Mary Turyk, Constance A. Benson, et al.. (1997). The efficacy and safety of Skinner herpes simplex vaccine towards modulation of herpes genitalis; report of a prospective double-blind placebo-controlled trial. Medical Microbiology and Immunology. 186(1). 31–36. 25 indexed citations
9.
Nagachinta, Tippavan, et al.. (1996). Unrecognized HIV-1 Infection in Inner-City Hospital Emergency Department Patients. Infection Control and Hospital Epidemiology. 17(3). 174–177. 1 indexed citations
10.
Sarin, Prem S., Paul H. Naylor, Jeffrey Kahn, et al.. (1994). Cytotoxic and humoral immune responses to HIV-1 p17 synthetic peptide HGP-30 in human volunteers. 3(1). 49–57. 1 indexed citations
11.
Yellin, Albert E., Thomas V. Berne, Maria D. Appleman, et al.. (1994). A randomized study of cefepime versus the combination of gentamicin and meziocillin as an adjunct to surgical treatment in patients with acute cholecystitis. International Journal of Gynecology & Obstetrics. 46(3). 352–352. 16 indexed citations
12.
Stryker, Richard, et al.. (1992). A Phase I Study of HGP-30, a 30 Amino Acid Subunit of the Human Immunodeficiency Virus (HIV) p17 Synthetic Peptide Analogue Sub-unit Vaccine in Seronegative Subjects. AIDS Research and Human Retroviruses. 8(8). 1321–1325. 18 indexed citations
13.
Okamoto, Mark P., Mark A. Gill, Alfred Chin, et al.. (1992). Tissue Concentrations of Cefepime in Acute Cholecystitis Patients. Therapeutic Drug Monitoring. 14(3). 220–225. 15 indexed citations
14.
Ruff, Michael R., Craig C. Smith, Howard S. Jaffe, et al.. (1991). Pharmacokinetics of peptide T in patients with Acquired Immunodeficiency Syndrome (AIDS). Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15(6). 791–801. 6 indexed citations
15.
Roberts, Richard B., F. Blaine Hollinger, Wade P. Parks, et al.. (1990). A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy. AIDS. 4(1). 67–72. 14 indexed citations
16.
Appleman, Maria D., Peter N.R. Heseltine, & C. E. Cherubin. (1990). Epidemiology, Antimicrobial Susceptibility, Pathogenicity, and Significance of Bacteroides fragilis Group Organis,s Isolated at Los Angeles County-University of Southern California Medical Center. Clinical Infectious Diseases. 13(1). 12–18. 41 indexed citations
17.
Ormerod, L. David, Peter N.R. Heseltine, Eduardo C. Alfonso, et al.. (1989). GENTAMICIN-RESISTANT PSEUDOMONAL INFECTION. Cornea. 8(3). 195???199–195???199. 12 indexed citations
18.
Heseltine, Peter N.R. & Michael L. Corrado. (1987). Compassionate use of norfloxacin. The American Journal of Medicine. 82(6). 88–92. 8 indexed citations
19.
Berne, Thomas V., et al.. (1982). Antibiotic management of surgically treated gangrenous or perforated appendicitis. The American Journal of Surgery. 144(1). 8–13. 104 indexed citations
20.
Heseltine, Peter N.R., David F. Busch, Richard D. Meyer, & Sydney M. Finegold. (1977). Cefoxitin: Clinical Evaluation in Thirty-Eight Patients. Antimicrobial Agents and Chemotherapy. 11(3). 427–434. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kjell Alestig Breakdown of academic impact, for papers by Phillip F. Pierce Breakdown of academic impact, for papers by Dante Bassetti Breakdown of academic impact, for papers by Ragnar Norrby Breakdown of academic impact, for papers by Richard J. Duma Breakdown of academic impact, for papers by Y Mouton Breakdown of academic impact, for papers by R. F. Jacobs Breakdown of academic impact, for papers by Darwin L. Palmer Breakdown of academic impact, for papers by E Soriano Breakdown of academic impact, for papers by E. J. C. Goldstein
Rankless by CCL
2026